The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
The drug is priced at Rs 2000 for a course of 40 tablets
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
The virtual world makes it possible to visualize, test, understand and predict what cannot be seen, before a patient is treated
The first pilot study from India analyzing Covaxin-Covishield mixed doses
The Health ID will allow users to connect with different healthcare providers and enable a consent-based sharing of personal health records
A toll-free helpline to be set up to help doctors and patients
Celltrion plans to provide dual treatment options for COVID-19; Regkirona for hospitalised patients and a nebulised cocktail therapy (CT-P63 in combination with Regkirona) for at- home settings
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
The glucometer connects to one’s smartphone and provides actionable diagnostic information
Subscribe To Our Newsletter & Stay Updated
